# A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

> **NCT01436513** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 72 (actual)

## Conditions studied

- Primary Ovarian Insufficiency
- Vaginitis
- Metrorrhagia
- Menopause

## Interventions

- **DRUG:** Premarin reference tablet (fasted)
- **DRUG:** Premarin new tablet (fasted)
- **DRUG:** Premarin reference tablet (fed)
- **DRUG:** Premarin new tablet (fed)

## Key facts

- **NCT ID:** NCT01436513
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2012-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436513, "A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01436513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*